How are semax and selank dosed and mixed?

500 mcg of Semax + Selank from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

Every vial at a glance. Pick a cell to draw it on the syringe.

Concentration is the vial's amount over its water; units are the dose over the concentration, times 100, on a U-100 syringe.
Vial1 mL of water2 mL of water3 mL of water
5 mg5 mg/mL: 250 mcg is 5 units, 400 mcg is 8 units, 500 mcg is 10 units2.5 mg/mL: 250 mcg is 10 units, 400 mcg is 16 units, 500 mcg is 20 units1.667 mg/mL: 250 mcg is 15 units, 400 mcg is 24 units, 500 mcg is 30 units
10 mg10 mg/mL: 250 mcg is 2.5 units, 400 mcg is 4 units, 500 mcg is 5 units5 mg/mL: 250 mcg is 5 units, 400 mcg is 8 units, 500 mcg is 10 units3.333 mg/mL: 250 mcg is 7.5 units, 400 mcg is 12 units, 500 mcg is 15 units

Jump to a vial 5 mg 10 mg

The Peptogen Semax leaflet gives, for intellectual-mnestic disorders with vascular brain lesions, 2 to 3 drops of the 0.1% drops in each nasal passage 4 times a day for 10 to 14 days (800 to 8,000 mcg a day).1

Vial strengths, mixing and syringe marks

500 mcg of Semax + Selank from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

500 mcg of Semax + Selank from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.

Of the people who logged semax, 75% set up a 10 mg vial and 15% a 5 mg vial; for selank, 83% set up a 10 mg vial.13 For mixing, 45% of the people who logged semax and 45% of those who logged selank set up 10 mg with 2 mL.13 The worked example and calculator are set to 10 mg with 2 mL and 500 mcg; 36% of the people who logged semax and 36% of those who logged selank set up 500 mcg, each on its own, not as a blend.13

None of the sources cited here gives a water volume for mixing either powder; the registered products are ready-made nasal drops. A laboratory paper on seized preparations (Vanhee), whose samples contained Selank and Semax, reports that an online search showed research peptides of this kind sold as lyophilized powder for injection or in nasal sprays.2 On a U-100 syringe, 100 units are 1 mL.3

Products and routes

The Peptogen leaflet for Semax gives 0.1% nasal drops in 3 mL, with 50 mcg a drop (500 mcg a drop in the 1% drops).1 It says the drops are applied intranasally, with not more than 2 to 3 drops in each nasal passage.1 For a moderate stroke, the leaflet gives 2 to 3 drops of the 1% drops in each nostril 3 to 4 times a day; for a severe stroke, 3 to 4 drops in each nostril 4 to 5 times a day.1 No label or human trial cited here states an injection route or site for either peptide.

What the human trials used

The trials cited here give a dose only for semax; for selank the only dose located is in a Russian register entry.

TrialDose and schedulePeopleLength
Gusev 1997, semaxDaily 12 mg (moderate stroke) or 18 mg (severe stroke), the doses with the best effect30 in the acute period of hemispheric ischemic stroke given semax within combined intensive therapy, 80 controls on conventional therapyCourses of 5 and 10 days4
Gusev 2018, semaxStandard regimen 6,000 mcg a dayOne hundred and ten after ischemic stroke, in early and late rehabilitation groups, each split into semax+ and semax- subgroups2 courses of 10 days, 20-day interval5
Serdiuk 2007, semax 1% intranasal12 mg a day27 with motor neuron diseaseTwo 10-day courses, 2-week break6
Polunin 2000, semaxNasal drops (group 1) or endonasal electrophoresis (group 2); no dose statedPeople with optic nerve disease in 3 groups, group 3 a control; numbers not statedNot stated7
Zozulia 2008, selankNot statedPeople with generalized anxiety disorder and neurasthenia: 30 on selank, 32 on medazepamNot stated8
Medvedev 2014, selankNot stated60 in total with phobic-anxiety and somatoform disorders, selank compared with phenazepamNot stated9
Medvedev 2015, selankNot statedPeople with anxiety-phobic, hypochondriac and somatoform disorders: 40 on selank plus phenazepam, 30 on phenazepam aloneNot stated10
Uchakina 2008, selankNot statedPeople with generalized anxiety disorder and neurasthenia; number not stated14 days11

What people log

Of the people who logged semax, 36% set up a 500 mcg dose and 10% a 400 mcg dose.13 For selank, 36% logged 500 mcg and 17% logged 250 mcg.13 Of the people who logged semax, 72% recorded under the skin and 21% nasal; for selank it was 76% and 22%.13

Storage

The Semax leaflet says to store the drops in the dark at no more than 10 °C and not to freeze.1 None of the sources cited here gives storage for the powder or how long a mixed vial keeps.

Frequently asked questions

Is there an approved label for semax or selank?

A DailyMed search for semax and selank found no labels. Apart from the Peptogen manufacturer leaflet for Semax, the only labels located were Russian register entries for Semax and Selank drops; European, Australian and UK regulators were not searched. The FDA agenda for its July 23-24, 2026 Pharmacy Compounding Advisory Committee lists Semax-related bulk drug substances as being considered for inclusion on the list of bulk drug substances that can be used to compound drug products under section 503A.12

Have semax and selank been studied together?

No human trial of semax and selank together was located; a ClinicalTrials.gov search showed no semax studies and no studies of the selank peptide.

What do the sources say about safety?

The Semax leaflet lists as contraindications hypersensitivity to its components, children under 7 (under 18 in ophthalmic and neurosurgical practice; no clinical studies have been conducted), pregnancy and lactation (no clinical studies have been conducted), acute psychotic states, disorders accompanied by anxiety, and a history of cramps.1 The leaflet says prolonged use may cause a mild irritation of the nasal mucosa; no safety statement for Selank was quoted for this guide.1

How the logged figures are counted

Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.

References

  1. Peptogen (Semax instruction leaflet). INTERNATIONAL NON-PROPRIETARY NAME (INN): methionyl-glutamyl-histidyl-. cdn.shopify.com
  2. PubMed. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind. 2020. pubmed.ncbi.nlm.nih.gov
  3. MedlinePlus (US National Library of Medicine). Giving an insulin injection: MedlinePlus Medical Encyclopedia. medlineplus.gov
  4. PubMed. [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. 1997. pubmed.ncbi.nlm.nih.gov
  5. PubMed. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. 2018. pubmed.ncbi.nlm.nih.gov
  6. PubMed. [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]. 2007. pubmed.ncbi.nlm.nih.gov
  7. PubMed. [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]. 2000. pubmed.ncbi.nlm.nih.gov
  8. PubMed. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. 2008. pubmed.ncbi.nlm.nih.gov
  9. PubMed. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. 2014. pubmed.ncbi.nlm.nih.gov
  10. PubMed. [Optimization of the treatment of anxiety disorders with selank]. 2015. pubmed.ncbi.nlm.nih.gov
  11. PubMed. [Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. 2008. pubmed.ncbi.nlm.nih.gov
  12. US FDA. July 23-24, 2026 Pharmacy Compounding Advisory Committee (PCAC) Meeting. fda.gov
  13. Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted